Atinvicitinib is a kind of pyrazole compound. Atinvicitinib has the potential for the research of atopic dermatitis (extracted from patent WO2021123094A1).
References:
[1]. Mohamad Morsey, et al. Bispecific caninized antibodies and bispecific binding partners for treating atopic dermatitis. Patent WO2021123094A1.
















